Presentazioni Orali Giovani Ricercatori 2023


Bookmark and Share

 


Spring Meeting Giovani Ricercatori SID-SIIA-SIMI-SIPREC-SISA 2023

Comunicazioni orali: 8+2 min

 


Domenica 16 Aprile 2023

 


14.30-16.00

Sessione 1 - Il lato oscuro del metabolismo delle lipoproteine
Moderatori: Fabio Fimiani, Ilaria Rossi

Basic research - Verso la definizione del ruolo di PCSK9 oltre il fegato…
• Lorenzo Da Dalt (Milano)
Clinical research - Lipoproteina(a) tra aterotrombosi e infiammazione: luci e ombre
• Vanessa Bianconi (Perugia)

Comunicazioni orali

Serum and cerebrospinal fluid concentrations of PCSK9 and hydroxysterols in patients with cognitive impairment

• Papotti Bianca
Thrombocytopenia and Kidney disease, two possible hallmark of FCS phenotype: preliminary evidence from a cohort study
• Tramontano Daniele
Digital droplet PCR versus real-time PCR in genetic characterization of lipoprotein(a) kringle IV type 2 repeat polymorphism
• Orsi Rebecca
Diagnosis of familial hypercholesterolemia in a large cohort of italian genotyped hypercholesterolemic patients
• Brucato Federica
Plasma levels of proprotein convertase subtilisin/kexin type 9 are inversely associated with N-terminal pro B-type natriuretic peptide in older men and women
• Pepa Matteo
Effectiveness of siRNA on LDL-C and Lp(a) levels: emerging real-life data
• Cipollone Alessia

 


 


Lunedì 17 Aprile 2023



08.30-10.10

Sessione 2 - Come il cuore si scompensa: l’origine del male
Moderatori: Damiano D’Ardes, Francesco Spannella

Basic research - Meccanismi dell’insufficienza cardiaca: dalle basi molecolari ai modelli preclinici
• Michele Ciccarelli (Salerno)
Clinical research - Dall'ipertensione arteriosa all'HFpEF passando per il danno d'organo cardiaco
• Costantino Mancusi (Napoli)

Comunicazioni orali

Mild cognitive impairment is associated with subclinical left ventricular dysfunction as assessed by global longitudinal strain in hypertensive patients
• Loria Francesco
Effects of PCSK9 inhibitors on arterial structure and function: preliminary results
• Busti Andrea
Effects of high glucose on PCSK9 expression in aortic vascular smooth muscle cells from insulin-sensitive and insulin-resistant Zucker rat: role of PCSK9 inhibitors
• Melchionda Elena
Biomarkers of mitochondrial dysfunction and inflammaging in older adults and blood pressure variability
• Bencivenga Leonardo
Circulating leptin concentration is associated with an increase in differential pressure values and development of arterial stiffness in adult male - The Olivetti Heart Study
• Forte Angelo
Effects of lifestyle advice associated with beetroot-based nutraceutical on 24-hour blood pressure in a population with high-normal blood pressure or grade 1 hypertension
• Poliseno Chiara



14.30-16.10

Sessione 3 - Scompenso cardiaco: dai meccanismi molecolari alla sala di emodinamica
Moderatori: Massimiliano Cavallo, Giovanna Gallo

Basic research - Meccanismi molecolari alla base dello scompenso cardiaco: focus sull’autofagia
• Maurizio Forte (Napoli)
Clinical research - Nuove frontiere del trattamento interventistico dello scompenso cardiaco
• Beniamino Pagliaro (Milano)

Comunicazioni orali

How age and gender affect hemodynamic forces in healthy subjects
• Airale Lorenzo
Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure
• Fiori Emiliano
Dapagliflozin counteracts the pro-apoptotic effects of the secretome of visceral adipose cells from obese subjects in human cardiac progenitor cells via the SGLT2 co-transporter
• Palma Giuseppe
The effect of dapagliflozin in a real-world population of HFrEF patients: symptoms, quality of life and echocardiographic parameters
• Di Fonzo Rosanna
Association of NDUFC2 polymorphic variants with left ventricular hypertrophy in human hypertension
• De Fazio Ludovica
Association between liver fibrosis and decreased myocardial mechano-energetic efficiency in individuals with different degree of glucose tolerance
• Mazzanti Camilla



16.40-18.20

Sessione 4 - Il sistema immunitario: attore (non?) protagonista nella malattia metabolica nel fegato
Moderatori: Francesco Baratta, Giulio Francesco Romiti

Basic research - …from bench
• Moris Sangineto (Bari)
Clinical research - ...to bedside
• Andrea Dalbeni (Verona)

Comunicazioni orali

Glomerular Hyperfiltration: a new marker of fibrosis severity in non-cirrhotic NAFLD
• Garbin Marta
Role of ASGR1 on obesity and metabolic syndrome
• Svecla Monika
Improvement in hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes treated with SGLT2 inhibitors: a five years follow-up.
• Currà Jaqueline
The spectrum of fatty liver disease and the role of genetic, metabolic and lifestyle factors associated with its severity in heterozygous apolipoprotein B-related familial hypobetalipoproteinemia
• D’Avino Michela
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience
• Bosco Giosiana
A novel endogenous hormone regulates lipolysis in adipose tissue and lipid accumulation in the Liver and skeletal Muscle
• Maurotti Samantha

 


 


Martedì 18 Aprile 2023

 


08.30-10.10

Sessione 5 - Oltre la glicemia: effetti pleiotropici dei GLP1Ras
Moderatori: Stefano Ciardullo, Sara Coluzzi

Basic research - Evidenze precliniche di nuove possibili applicazioni terapeutiche dei GLP1Ras
• Nicola Marrano (Bari)
Clinical research - GLP1Ras e NAFLD-NASH
• Alessandro Mantovani (Verona)

Comunicazioni orali

GLP-1 receptor agonists counteract the deleterious effects of pasireotide on pancreatic beta-cell survival and function
• Biondi Giuseppina
Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes
• Longo Miriam
Short-term treatment with dapagliflozin increases the hepatic expression and synthesis of FGF-21 in lean but not obese mice
• Di Vincenzo Angelo
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and glucose uptake in human type 2 diabetes
• Capece Umberto
Exploring the role of FXR signaling in maintaining ileal mucosa integrity in subjects with altered glucose tolerance conditions
• De Vito Francesca
Hyperglycemic conditions promote early progression of calcific aortic valve disease in animal models and isolated valve interstitial cells
• Donato Maristella